Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN EXPRESS COAXP · Entity 2839 | Director | December 31, 2021 | February 02, 2022 |
| BOEING COBA · Entity 2862 | Director | April 01, 2024 | April 04, 2024 |
| Envision Healthcare CorpEVHC · Entity 162981 | Director | May 25, 2017 | May 30, 2017 |
| JOHNSON & JOHNSONJNJ · Entity 2722 | Director | February 15, 2022 | February 17, 2022 |
| Warby Parker Inc.WRBY · Entity 4234 | Director | June 08, 2026 | June 10, 2026 |
| agilon health, inc.AGL · Entity 4698 | Director | June 02, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN EXPRESS CO
Report date December 31, 2021 · Filed February 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,625 |
Reported balance
After 2021-12-14 transaction · row 1
1 source rowRow 1 · 2021-12-14 · Gift · Disposed 28,500 · Balance 30,625 F1: The reported disposition represents a bona fide charitable gift made by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported disposition represents a bona fide charitable gift made by the reporting person.
BOEING CO
Report date April 01, 2024 · Filed April 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 26,222.747 |
Reported balance
After 2024-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-04-01 · Grant · Acquired 240.054 · Balance 26,222.747 F1: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2: Phantom stock units awarded or acquired in lieu of director cash compensation. F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Phantom stock units are convertible into common stock on a 1-for-1 basis.
F2: Phantom stock units awarded or acquired in lieu of director cash compensation.
F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.
Envision Healthcare Corp
Report date May 25, 2017 · Filed May 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 182,573 |
Reported balance
After 2017-05-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-05-25 · Grant · Acquired 3,124 · Balance 182,573 F1: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. F2: The number of shares of common stock reported as beneficially owned by the reporting person has been reduced in order to correct a clerical error in the previous Form 4 filing. All reportable transactions have been previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company.
F2: The number of shares of common stock reported as beneficially owned by the reporting person has been reduced in order to correct a clerical error in the previous Form 4 filing. All reportable transactions have been previously reported.
JOHNSON & JOHNSON
Report date February 15, 2022 · Filed February 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 25,673 |
Reported balance
After 2022-02-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-15 · Grant · Acquired 1,175 · Balance 25,673 F1: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
Warby Parker Inc.
Report date June 08, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 113,629 |
Reported balance
After 2026-06-08 transaction · row 1
1 source rowRow 1 · 2026-06-08 · Grant · Acquired 13,006 · Balance 113,629 F1: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 9,173 |
Reported balance
Holding disclosure · report date 2026-06-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,173 F2: Mr. Williams may be deemed to have voting power and dispositive power over the shares held by the Ronald A. Williams Revocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death.
F2: Mr. Williams may be deemed to have voting power and dispositive power over the shares held by the Ronald A. Williams Revocable Trust.
agilon health, inc.
Report date June 02, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 149,141 |
Reported balance
After 2026-06-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 2,133 · Balance 149,141 F1: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. F3: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director
F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
F3: Includes restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Envision Healthcare Holdings, Inc.
Report date December 01, 2016 · Filed December 02, 2016
Section 16 reporting ended · disclosed 2016-12-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-01 transaction · row 1
1 source rowRow 1 · 2016-12-01 · Disposition to issuer · Disposed 535,941 · Balance 0 F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.
F2: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 10, 2026 20:58 UTC | Warby Parker Inc. WRBY · Entity 4234 | GrantClass A Common Stock | 13,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001185243-26-000002 · wk-form4_1781125109.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,629 F1 · shares: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:56 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 2,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041024 · wk-form4_1780624613.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,141 F1 · shares: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director F2 · balance_after: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. F3 · balance_after: Includes restricted stock units. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 23:02 UTC | Warby Parker Inc. WRBY · Entity 4234 | GrantClass A Common Stock | 17,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-059022 · tm2517865-4_4seq1.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,623 F1 · shares: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. Read SEC document |
| May 28, 2025 Filed May 30, 2025 22:27 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 78,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028716 · wk-form4_1748643994.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,675,257 F1 · shares: Restricted stock units that vest in full on May 28, 2026, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 21:00 UTC | Warby Parker Inc. WRBY · Entity 4234 | GrantClass A Common Stock | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-110601 · tm2426641-1_4seq1.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,261 F1 · shares: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program, in connection with Mr. Williams's appointment as Chair of the Nominating and Corporate Governance Committee. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:31 UTC | Warby Parker Inc. WRBY · Entity 4234 | GrantClass A Common Stock | 790 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-085843 · tm2420880-3_4seq1.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,846 F1 · shares: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program, in connection with Mr. Williams' appointment as Lead Director. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 01:31 UTC | Warby Parker Inc. WRBY · Entity 4234 | GrantClass A Common Stock | 19,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-070570 · tm2417040-8_4seq1.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,056 F1 · shares: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. Read SEC document |
| May 29, 2024 Filed Jun 1, 2024 00:57 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 32,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026129 · wk-form4_1717203424.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,596,533 F1 · shares: Restricted stock units that vest in full on May 29, 2025, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 00:00 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 240.054 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004944 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,222.747 Underlying: Common Stock · 240.054 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:54 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 150,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000958 · wk-form4_1704837247.xml · derivative · entry 4 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on April 27, 2017, and fully vested on September 14, 2021. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:54 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 950,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000958 · wk-form4_1704837247.xml · derivative · entry 3 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 950,000 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on December 30, 2016, and fully vested on July 1, 2020. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:54 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 150,000 | $3.00 | $450,000.00 |
DisclosureSEC source: 0001628280-24-000958 · wk-form4_1704837247.xml · nonDerivative · entry 2 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,564,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:54 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 950,000 | $1.00 | $950,000.00 |
DisclosureSEC source: 0001628280-24-000958 · wk-form4_1704837247.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,414,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 00:08 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 348.408 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000428 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,982.693 Underlying: Common Stock · 348.408 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 23:34 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 467.881 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009354 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,634.285 Underlying: Common Stock · 467.881 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 22:03 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 420.209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007374 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,166.404 Underlying: Common Stock · 420.209 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:37 UTC | Warby Parker Inc. WRBY · Entity 4234 | GrantClass A Common Stock | 25,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-070465 · tm2318444-5_4seq1.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,332 F1 · shares: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU unit represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:52 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024681 · doc4.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,464,414 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 23:41 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 411.737 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004695 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,746.195 Underlying: Common Stock · 411.737 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:24 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 455.625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000421 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,334.458 Underlying: Common Stock · 455.625 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:50 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 715.236 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010842 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,878.837 Underlying: Common Stock · 715.236 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| July 01, 2022 Filed Jul 7, 2022 00:20 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 640.355 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-008692 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,163.601 Underlying: Common Stock · 640.355 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| June 09, 2022 Filed Jun 14, 2022 01:03 UTC | Warby Parker Inc. WRBY · Entity 4234 | GrantClass A Common Stock | 16,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-070669 · tm2218339-4_4seq1.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,408 F1 · shares: Represents a grant of fully-vested restricted stock units ("RSUs"), granted pursuant to the Warby Parker Inc. Amended and Restated Non-Employee Director Compensation Program. Each RSU represents a right to receive one share of Class A Common Stock. The RSUs will be settled in shares of Class A Common Stock following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; or (iii) the director's death. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 21:00 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025026 · doc4.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,458,792 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:26 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 465.396 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005606 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,523.246 Underlying: Common Stock · 465.396 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002584 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,673 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:19 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 428.86 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000501 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,057.85 Underlying: Common Stock · 428.86 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| December 14, 2021 Filed Feb 2, 2022 02:56 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GiftCommon Stock | 28,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002887 · form5.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,625 F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 22:30 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 396.81 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-012940 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,628.99 Underlying: Common Stock · 396.81 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| September 30, 2021 Filed Oct 5, 2021 00:16 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 104.713 | $169.33 | $17,731.05 |
DisclosureSEC source: 0001127602-21-026553 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,412.2403 Underlying: Common Stock · 104.713 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 00:16 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 369.48 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-010330 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,232.18 Underlying: Common Stock · 369.48 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:56 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 113.802 | $164.76 | $18,750.02 |
DisclosureSEC source: 0001127602-21-021380 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,114.4233 Underlying: Common Stock · 113.802 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:03 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 1,339.136 | $149.35 | $199,999.96 |
DisclosureSEC source: 0001127602-21-015689 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,798.8423 Underlying: Common Stock · 1,339.136 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 21:35 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 6,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027025 · doc4.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,451,856 F1 · shares: Restricted stock units that vests in full on April 14, 2022, subject to continued service as a director. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:48 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 348.59 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-006521 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,862.7 Underlying: Common Stock · 348.59 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:15 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 132.875 | $141.11 | $18,749.99 |
DisclosureSEC source: 0001127602-21-012757 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,459.7063 Underlying: Common Stock · 132.875 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002229 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,884.495 Underlying: Common Stock · 1,123 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:23 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 430.1 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000581 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,514.11 Underlying: Common Stock · 430.1 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 22:43 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 159.087 | $117.86 | $18,749.99 |
DisclosureSEC source: 0001127602-21-000784 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,078.4203 Underlying: Common Stock · 159.087 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:13 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 524.64 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012158 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,084.01 Underlying: Common Stock · 524.64 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 19:35 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 189.624 | $98.88 | $18,750.02 |
DisclosureSEC source: 0001127602-20-026184 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,646.2163 Underlying: Common Stock · 189.624 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 21:11 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 478.89 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009640 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,559.37 Underlying: Common Stock · 478.89 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:27 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 190.859 | $98.24 | $18,749.99 |
DisclosureSEC source: 0001127602-20-020822 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,147.0739 Underlying: Common Stock · 190.859 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| May 05, 2020 Filed May 7, 2020 19:10 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 2,325.58 | $86.00 | $199,999.88 |
DisclosureSEC source: 0001127602-20-015732 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,618.4949 Underlying: Common Stock · 2,325.58 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 22:16 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 646.91 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-006072 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,080.48 Underlying: Common Stock · 646.91 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 19:13 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 226.998 | $82.60 | $18,750.03 |
DisclosureSEC source: 0001127602-20-012607 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,292.9149 Underlying: Common Stock · 226.998 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002162 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149.454 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 23:23 UTC | BOEING CO BA · Entity 2862 | GrantPhantom Stock Units · Derivative | 268.51 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000569 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,287.37 Underlying: Common Stock · 268.51 shares Expires not disclosed F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:46 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 150.192 | $124.84 | $18,749.97 |
DisclosureSEC source: 0001127602-20-000759 · form4.xml · derivative · entry 2 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,838.8249 Underlying: Common Stock · 150.192 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F4 · kind: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F5 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:46 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 310.397 | $124.84 | $38,749.96 |
DisclosureSEC source: 0001127602-20-000759 · form4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,688.6329 Underlying: Common Stock · 310.397 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.